Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Medivation Announces Participation at Upcoming Investor Conference


Print article Print article
© Marketwire 2014
2014-01-31 22:53:01 -

SAN FRANCISCO, CA -- (Marketwired) -- 01/31/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:



  • David Hung, M.D., president and chief executive officer, will present at the Leerink Global Healthcare Conference on Wednesday, February 12 at 11:30am ET at the Waldorf Astoria Hotel, New York, NY.






Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm : ctt.marketwire.com/?release=1086405&id=3850687&type=1&am .. . A replay of the webcast will be available on the Company's website for 30 days following the live event.



About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com : ctt.marketwire.com/?release=1086405&id=3850690&type=1&am .. .




Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com